The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of TGFβ type I receptor inhibitor, galunisertib, plus neoadjuvant chemoradiation in patients with locally advanced rectal cancer.
 
Kristina Hoot Young
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent
 
Andrew J Gunderson
Employment - Thermo Fisher Scientific (I)
Research Funding - Bristol-Myers Squibb (Inst)
 
Miranda Gilchrist
Employment - Thermofisher Scientific Biomarkers
 
Mark Whiteford
No Relationships to Disclose
 
Maria X Kiely
No Relationships to Disclose
 
Amanda Hayman
No Relationships to Disclose
 
David P O'Brien
No Relationships to Disclose
 
Rehan Ahmad
No Relationships to Disclose
 
Jeffrey V Manchio
No Relationships to Disclose
 
Evelyn Brosnan
Research Funding - Bristol-Myers Squibb (Inst)
 
Gina M. Vaccaro
Consulting or Advisory Role - Amgen; Array BioPharma; Astellas Pharma; AstraZeneca; Exelixis; Incyte; MSD; Pfizer; QED Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - Incyte
Research Funding - Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; E.R. Squibb Sons, LLC; Eisai; Foundation Medicine
 
Rui Li
Research Funding - Bristol-Myers Squibb (Inst)
 
Miklos Simon
Speakers' Bureau - Genomic Health
 
Mary McCormick
Research Funding - Bristol-Myers Squibb (Inst)
 
Ashley Drokin
Research Funding - Bristol-Myers Squibb (Inst)
 
Julie Cramer
Research Funding - Bristol-Myers Squibb (Inst)
 
Walter John Urba
Leadership - Leidos Biomedical Research
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - Leidos Biomedical Research
 
Michael Gough
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); VIR Biotechnology
Patents, Royalties, Other Intellectual Property - Providence Portland Medical Center; Providence Portland Medical Center (I)
 
Marka R. Crittenden
Research Funding - Bristol-Myers Squibb (I); Bristol-Myers Squibb (Inst); Jounce Therapeutics; Nanobiotix; VIR Biotechnology (I)
Patents, Royalties, Other Intellectual Property - Providence Portland Medical Center
 
Tomoko Yamazaki
Research Funding - Bristol-Myers Squibb (Inst)